HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients

Circulation

Volumn 99, Issue 21, 1999, Pages 2784-2790

  Guédez, Yajaira ^a,b   Kotby, Alyaa ^c   El Demellawy, Maha ^a,b   Galal, Ashraf ^e   Thomson, Glenys ^d   Zaher, Salah ^e   Kassem, Samir ^e   Kotb, Malak ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Memphis ^*

Author keywords

Antigens; Genetics; Rheumatic heart disease

Indexed keywords

HLA ANTIGEN CLASS 2;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEART PROTECTION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SEROLOGY;

EID: 18244417948     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.21.2784     Document Type: Article

References (42)

1. Markowitz M, Gerber MA. The Jones criteria for guidance in the diagnosis of rheumatic fever: another perspective. Arch Pediatr Adolesc Med. 1995;149:725-726.
2. Stollerman GH. Rheumatic fever. Lancet. 1997;349:935-942.
3. Shulman ST. Complications of streptococcal pharyngitis. Pediatr Infect Dis J. 1994;13(suppl 1):S70-S74.
4. Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century: influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation. 1993; 88:1964-1972.
5. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991;325:783-793.
6. Zabriskie JB, Gibofsky A. Genetic control of the susceptibility to infection with pathogenic bacteria. Curr Top Microbiol Immunol. 1986; 124:1-20.
7. Ayoub EM. Acute rheumatic fever. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Heart Disease in Infants, Children, and Adolescents. 5th ed. Baltimore, Md: Williams & Wilkins; 1995:1400-1416.
8. Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J. 1997;16:400-407.
9. Sanyal SK. Long-term sequelae of the first attack of acute rheumatic fever during childhood. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Heart Disease in Infants, Children and Adolescents. 5th ed. Baltimore, Md: Williams & Wilkins; 1995:1416-1440.
10. DiSciascio G, Taranta A. Rheumatic fever in children. Am Heart J. 1980;99:635-658.
11. Pickles WN. Rheumatic family. Lancet. 1943;2:241.
12. Monplaisir N, Valette I, Bach J-F. HLA antigens in 88 cases of rheumatic fever observed in Martinique. Tissue Antigens. 1986;28:209-213.
13. Debaz H, Olivo A, Perez-Luque E, Vasquez-Garcia MN, Burguete A, Chavez-Negrete A, Velasco C, Arguero R, Gorodeszky C. DNA Analysis of class II alleles in rheumatic heart disease in Mexicans. 22nd Annual ASHI Meeting Abstracts. Human Immunology. 1996;49(suppl):63.
14. Koyanagi T, Koga Y, Nishi H, Toshima H, Sasazuki T, Imaizumi T, Kimura A. DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J Mol Cell Cardiol. 1996;28:1349-1353.
15. Weidebach W, Goldberg AC, Chiarella JM, Guilherme L, Snitcowsky R, Pileggi F, Khalil J. HLA class II antigens in rheumatic fever: analysis of the DR locus by restriction fragment-length polymorphism and oligo-typing. Hum Immunol. 1994;40:253-258.
16. Ozkan M, Carin M, Sonmez G, Senocak M, Ozdemir M, Yakut C. HLA antigens in Turkish race with rheumatic heart disease. Circulation. 1993; 87:1974-1978.
17. Taneja V, Mehra NK, Reddy S, Narula J, Tandon R, Vaidya MC, Bhatia ML. HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Circulation. 1989;80: 335-340.
18. Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Khalil J. Association of human leukocyte class II antigens with rheumatic heart disease in Brazilian population. Circulation. 1991;83:1995-1998.
19. Rajapakse CNA, Halim K, Al-Orainey I, Al-Nozha M, Al-Aska AK. A genetic marker for rheumatic heart disease. Br Heart J. 1987;58: 659-662.
20. Ayoub EM, Barret DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest. 1986;77:2019-2026.
21. Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatia ML. HLA, blood groups and secretor status in patients with established rheumatic heart disease. Tissue Antigens. 1986;27:172-178.
22. Anastasiou-Nana MI, Anderson JL, Carquist JF, Nanas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J. 1986;112:992-997.
23. Maharaj B, Hammond MG, Appadoo B, Leary WP, Phil D, Pudifin DJ. HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation. 1987;76:259-261.
24. Dajani AS, Bisno AL, Chung KJ, Durack DT, Gerber MA, Kaplan EL, Millard HD, Randolph MF, Shulman ST, Watanakunakorn C. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268:2069-2073.
25. Kotby AA, El-Monim MTA, Hassan AS. Assessment of rheumatic fever and rheumatic heart disease in the Children's Hospital of Ain Shams University from 1981-1995. Egypt J Pediatr. 1996;13:183-205.
26. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991;10:506-513.
27. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225-235.
28. Olerup O, Zetterquist H. DR low-resolution PCR-SSP typing: a correction and an up-date. Tissue Antigens. 1993;41:55-56.
29. Bignon JD, Fernandez-Vina MA, Cheneau ML, Faucet R, Schreuder GMT, Clayton J, Marsh SGE, Charron D. HLA DNA class II typing by PCR-SSOP: 12th International Histocompatibility Workshop experience. In: Charron D, ed. HLA: Genetic Diversity of HLA: Functional and Medical Implications. Paris, France: EDK; 1997:21-25.
30. Buyse I, Decorte R, Baens M, Cuppens H, Semana G, Emonds MP, Marynen P, Cassiman JJ. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens. 1993;41:1-14.
31. Hors J, El Chenawi S, Djoulah S, Hafez M, Abbas F, El Borai MH, Kamel M, Abbal M, Cambon-Thomsen A, Mercier P, Reviron D, Magzoub MA, Rosner G, Delgado JC, Yunis E, Raffoux C, Tamouza R, Izaabel H, Hmida S, Benhamamouch S, Bessaoud K, Langaney A, Sanchez-Mazas A. HLA in North African populations: 12th International Histocompatibility Workshop NAFR report. In: Charron D, ed. HLA: Genetic Diversity of HLA: Functional and Medical Implications. Paris, France: EDK; 1997:328-334.
32. Fernandez-Viña MA, Gao X, Moraes ME, Moraes JR, Salatiel I, Miller S, Tsai J, Sun Y, An J, Layrisse Z, Gazit E, Brautbar C, Stastny P. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics. 1991;34:299-312.
33. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet. 1955;19:251-253.
34. Payami H, Khan MH, Grennan DM, Sanders PA, Dyer PA, Thomson G. Analysis of genetic interrelationship among HLA-associated diseases. Am J Hum Genet. 1987;41:331-349.
35. Hill AVS. HLA and infection. J R Coll Physicians Lond. 1992;26:11-16.
36. Ayoub EM, Kotb M, Cunningham MW. Rheumatic fever pathogenesis. In: Stevens DL, Kaplan EL, eds. Streptococcal Infections. New York, NY: Oxford University Press: In press.
37. Thorsby E. HLA associated diseases. A summary of the 12th International Histocompatibility workshop component. In: Charron D, ed. HLA: Genetic Diversity of HLA: Functional and Medical Implications. Paris, France: EDK; 1996:91-96.
38. Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol. 1995;74:10-22.
39. Nepom GT. Class II antigens and disease susceptibility. Annu Rev Med. 1995;46:17-25.
40. Schmidt D, Verdager J, Nuzhat A, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med. 1997;186:1059-1075.
41. Sinha AA, Lopez MT, McDevit HO. Autoimmune diseases: the failure of self tolerance. Science. 1990;248:1380-1388.
42. McDevitt HO, Chinitz A. Genetic control of the antibody response: relationship between immune responses and histocompatibility (H-2) type. Science. 1969;163:1207-1208.